alexa
Reach Us +44-1235425476
Imaging Toxicity of Radiation Therapy in Liver | OMICS International | Abstract
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Imaging Toxicity of Radiation Therapy in Liver

Hesheng Wang*

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109, USA

*Corresponding Author:
Hesheng Wang
Department of Radiation Oncology
University of Michigan, Ann Arbor
MI, 48109, USA
E-mail: [email protected]

Received date: June 28, 2012; Accepted date: June 29, 2012; Published date: June 30, 2012

Citation: Wang H (2012) Imaging Toxicity of Radiation Therapy in Liver. J Nucl Med Radiat Ther S6:e001. doi:10.4172/2155-9619.S6-e001

Copyright: © 2012 Wang H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Increasing radiation dose for better hepatic cancer control from radiation therapy (RT) is limited by the development of radiationinduced liver disease (RILD). Clinical syndrome of RILD occurs typically 2 weeks to 4 months after completion of RT. In severe cases, RILD can lead to liver failure and death. Using the Lyman-Kutcher- Burman NTCP model, the likelihood of developing RILD can be estimated based on the planned dose on the normal liver [1]. However, the models solely based on dose distribution which ignores individual liver sensitivity to RT that may allow safe delivery of higher radiation dose on some patients. Imaging can quantitatively assess normal tissue response to RT, and thereby it may be able to characterize individual liver tolerance to radiation and provide surrogates to early predict the development of RILD.

Recommended Conferences

Clinical Oncology & Radiation Therapy

Singapore, Singapore
Share This Page
Top